Oxidative modification of serum proteins in multiple sclerosis

Neurochemistry International

Volumn 63, Issue 5, 2013, Pages 507-516

  Sadowska Bartosz, Izabela ^a   Adamczyk Sowa, Monika ^b   Galiniak, Sabina ^a   Mucha, Sebastian ^b   Pierzchala, Krystyna ^b   Bartosz, Grzegorz ^a,c  

^a UNIVERSITY OF RZESZÓW   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c UNIVERSITY OF LODZ   (Poland)

Author keywords

AOPP; Glycoxidation; Inflammation; Multiple sclerosis; Oxidative stress; Protein oxidation

Indexed keywords

BETA1A INTERFERON; C REACTIVE PROTEIN; CARBONYL DERIVATIVE; GLATIRAMER; INTERFERON BETA SERINE; KYNURENINE; PLASMA PROTEIN; THIOL GROUP; TRYPTOPHAN; TYROSINE DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN MODIFICATION; RELAPSE;

AOPP; GLYCOXIDATION; INFLAMMATION; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; PROTEIN OXIDATION;

ADULT; BLOOD PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OXIDATION-REDUCTION;

EID: 84884644413     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.08.009     Document Type: Article

References (33)

1. H.T. Besler, and S. Comocrossed d signlu Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis Nutr. Neurosci. 6 2003 189 196 (Pubitemid 36656698)
2. O.A. Bizzozero, G. DeJesus, and K. Callahan Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis J. Neurosci. Res. 81 2005 687 695 (Pubitemid 41532164)
3. A.T. Diplock, M.C.R. Symons, and C.A. Rice-Evans Techniques in Free Radical Research 1991 Elsevier Science Amsterdam, London, New York, Tokyo
4. J. Du, and J.M. Gebicki Proteins are major initial cell targets of hydroxyl free radicals Int. J. Biochem. Cell Biol. 36 2004 2334 2343 (Pubitemid 39094453)
5. G. Ellman Tissue sulfhydryl groups Arch. Biochem. Biophys. 82 1959 70 77
6. G. Ferretti, and T. Bacchetti Peroxidation of lipoproteins in multiple sclerosis J. Neurol. Sci. 311 2011 92 97
7. H. Gonzalo, L. Brieva, and F. Tatzber Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism J. Neurochem. 123 2012 622 634
8. B. György, E. Tóth, and E. Tarcsa Citrullination: a posttranslational modification in health and disease Int. J. Biochem. Cell Biol. 38 2006 1662 1677 (Pubitemid 43947646)
9. T. Hentle, R. Deppisch, and W. Beck Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds Nephrol. Dial. Transplant. 14 1999 1968 1975 (Pubitemid 29358896)
10. Ivica, J., Wilhelm, J. 2013. Lipophilic fluorescent products of free radicals. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., [Epub ahead of print].
11. R. Johnson, and J. Baker Assay of serum fructosamine: internal vs external standardization Clin. Chem. 33 1987 1955 1956
12. M. Kalousová, E. Havrdová, and K. Mrázová Advanced glycoxidation end products in patients with multiple sclerosis Prague Med. Rep. 106 2005 167 174
13. M. Koch, J. Mostert, and A.V. Arutjunyan Plasma lipid peroxidation and progression of disability in multiple sclerosis Eur. J. Neurol. 14 2007 529 533 (Pubitemid 46587841)
14. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1983 1444 1452 (Pubitemid 14237132)
15. S. Ljubisavljevic, I. Stojanovic, and S. Vojinovic The patients with clinically isolated syndrome and relapsing remitting multiple sclerosis show different levels of advanced protein oxidation products and total thiol content in sera and CSF Neurochem. Int. 62 2013 988 997
16. O.H. Lowry, N.J. Rosebrough, and A.L. Farr Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
17. F.D. Lublin, and S.C. Reingold Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis Neurology 46 1996 907 911
18. W.I. McDonald, A. Compston, and G. Edan Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis Ann. Neurol. 50 2001 121 127
19. R. Mironova, T. Niwa, and Y. Handzhiyski Evidence for non-enzymatic glycosylation of Escherichia coli chromosomal DNA Mol. Microbiol. 55 2005 1801 1811 (Pubitemid 40445214)
20. M.A. Moscarello, F.G. Mastronardi, and D.D. Wood The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis Neurochem. Res. 32 2007 251 256 (Pubitemid 46238870)
21. G. Munch, R. Kies, and A. Wessel Determination of advanced glycation end-products in serum by fluorescence spectroscopy and competitive ELISA Eur. J. Clin. Chem. Clin. Biochem. 35 1997 669 677
22. G. Pennisi, C. Cornelius, and M.M. Cavallaro Redox regulation of cellular stress response in multiple sclerosis Biochem. Pharmacol. 82 2011 1490 1499
23. A.Z. Reznick, and L. Packer Oxidative damage to proteins: spectrophotometric method for carbonyl assay Methods Enzymol. 233 1994 357 363
24. L.M. Sayre, P.I. Moreira, and M.A. Smith Metal ions and oxidative protein modification in neurological disease Ann. Ist. Super. Sanita. 41 2005 143 164 (Pubitemid 43169859)
25. J. Sellner, J. Kraus, and A. Awad The increasing incidence and prevalence of female multiple sclerosis-a critical analysis of potential environmental factors Autoimmun. Rev. 10 2011 495 502
26. G. Simonini, A. Pignone, and S. Generini Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis Toxicology 155 2000 1 15
27. M. Soilu-Hänninen, J.O. Koskinen, and M. Laaksonen High sensitivity measurement of CRP and disease progression in multiple sclerosis Neurology 65 2005 153 155 (Pubitemid 40967796)
28. Z. Sternberg, C. Hennies, and D. Sternberg Plasma pentosidine: a potential biomarker in the management of multiple sclerosis Mult. Scler. 17 2011 157 163
29. Z. Sternberg, C. Hennies, and D. Sternberg Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosis J. Neuroinflammation 7 2010 72
30. Z. Sternberg, P. Ostrow, and M. Vaughan AGE-RAGE in multiple sclerosis brain Immunol. Invest. 40 2011 197 205
31. M. Wållberg, J. Bergquist, and A. Achour Malondialdehyde modification of myelin oligodendrocyte glycoprotein leads to increased immunogenicity and encephalitogenicity Eur. J. Immunol. 37 2007 1986 1995 (Pubitemid 47065134)
32. V. Witko-Sarsat, M. Friedlander, and C. Capeillère-Blandin Advanced oxidation protein products as a novel marker of oxidative stress in uremia Kidney Int. 49 1996 1304 1313 (Pubitemid 26166404)
33. B. Zakrzewska-Pniewska, M. Styczynska, and A. Podlecka Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis Mult. Scler. 10 2004 266 271 (Pubitemid 38807452)